Physician profile
Jay Kiessling
NPI 1386731248
$4,434.16
in general payments reported to CMS, 2019-2025
28 companies · $792 in 2025
The $792 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $109 · 2021: $41.23 · 2022: $431 · 2023: $494 · 2024: $2,121 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,364 · Travel and Lodging: $1,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,364.06 |
| Travel and Lodging | $1,044.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,568.45 | 2022-2025 | Acticoat 4" X 4", Oasis, Pico |
| Organogenesis INC. | $424.42 | 2023-2025 | Puraply, Puraply Wound Matrix, Apligraf |
| Endologix LLC | $260.01 | 2019-2022 | |
| Canon Medical Systems USA, INC. | $200.64 | 2025 | Interventional Angiography System |
| Lemaitre Vascular, INC. | $162.24 | 2019-2025 | Restoreflow, Hydro Lemaitre Valvulotome |
| Kerecis Limited | $131.14 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Janssen Pharmaceuticals, INC | $78.13 | 2019-2020 | |
| Abbott Laboratories | $71.27 | 2022-2025 | Proclaim, Eterna |
| Osiris Therapeutics INC. | $68.71 | 2019 | |
| Polynovo North America LLC | $60.32 | 2022-2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $41.48 | 2019-2023 | Tcc-Ez |
| Tactile Systems Technology INC | $39.22 | 2019 | |
| Silk Road Medical, INC. | $36.90 | 2020 | |
| Reapplix INC. | $34.76 | 2023-2024 | 3c Patch Kit - Box |
| Shockwave Medical, INC | $29.66 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $22.87 | 2021 | |
| W. L. Gore & Associates, INC. | $22.51 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Abbvie INC. | $22.16 | 2023 | |
| Medtronic, INC. | $21.70 | 2025 | Endurant Iis |
| Molnlycke Health Care US, LLC | $20.37 | 2023 | Mepilex Border Post-Op Ag, Mepitel Ag, Exufiber Ag+ |
| Biotissue Holdings INC. | $18.36 | 2021 | |
| Kci USA, INC. | $18.04 | 2023 | V.A.C. Dermatac, Activ.A.C. |
| Mozarc Medical US LLC | $16.09 | 2023 | Chameleon |
| Cordis US Corp. | $15.19 | 2025 | Mynx Control |
| Urgo Medical North America, LLC | $14.19 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Bioventus LLC | $12.02 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.71 | 2019 | |
| Misonix INC | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Kiessling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.